Distribution and favorable prognostic implication of genomic EGFR alterations in IDH-wildtype glioblastoma.
Nayuta HigaToshiaki AkahaneTaiji HamadaHajime YonezawaHiroyuki UchidaRyutaro MakinoShoji WatanabeTomoko TakajoSeiya YokoyamaMari KirishimaKei MatsuoShingo FujioRyosuke HanayaAkihide TanimotoKoji YoshimotoPublished in: Cancer medicine (2022)
We found that the EGFR gene profiles of GBM differ among cohorts and that EGFR alterations are good prognostic markers of overall survival in patients with IDH-wildtype GBM. Additionally, we identified rare EGFR variants with longitudinal and temporal transformations of EGFRvIII.